Cargando…
Activating Mutations in ERBB2 and Their Impact on Diagnostics and Treatment
Despite the ongoing “war on cancer,” cancer remains one of the major causes of human morbidity and mortality. A new paradigm of targeted therapies holds the most promise for the future, making identification of tumor-specific therapeutic targets of prime importance. ERBB2/HER2, best known for its ro...
Autores principales: | Herter-Sprie, Grit S., Greulich, Heidi, Wong, Kwok-Kin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632856/ https://www.ncbi.nlm.nih.gov/pubmed/23630663 http://dx.doi.org/10.3389/fonc.2013.00086 |
Ejemplares similares
-
Posttranscriptional regulation of gene expression—adding another layer of complexity to the DNA damage response
por: Boucas, Jorge, et al.
Publicado: (2012) -
Palbociclib resistance confers dependence on an FGFR-MAP kinase-mTOR-driven pathway in KRAS-mutant non-small cell lung cancer
por: Haines, Eric, et al.
Publicado: (2018) -
Image-guided radiotherapy platform using single nodule conditional lung cancer mouse models
por: Herter-Sprie, Grit S., et al.
Publicado: (2014) -
Effectiveness of Trastuzumab Combined With Capecitabine Treatment in a Patient With Hilar Cholangiocarcinoma Complicated by Liver Metastases With an ERBB2-Activating Mutation: A Case Report
por: Zeng, Daobing, et al.
Publicado: (2022) -
ERBB2 Mutations as Potential Predictors for Recurrence in Colorectal Serrated Polyps by Targeted Next-Generation Sequencing
por: Wang, Qi-Wen, et al.
Publicado: (2022)